Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Molecular Therapy. Methods & Clinical Development|November 16, 2022
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-βKajal Chaudhry, Ashley Geiger, Ehsan Dowlati, et al.
Blood Cells, Molecules & Diseases|May 4, 2002
Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571Philipp le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 TrialTimothy Lin, Suqi Ke, Chen Hu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Pitfalls in 2HG detection with TE-optimized MRS at 3TSeyma Alcicek, Dunja Simicic, Lindsay Blair, et al.
Brain Pathology (Zurich, Switzerland)|July 24, 2026
ALT phenotype assessment in IDH-mutant astrocytoma supports biologic consequence of ATRX missense mutationsOguzhan O Kizilkaya, Kevin Y Zhang, Mohamed Sherief, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Clinical Trial Design and Development Work Group Within the Quantitative Imaging NetworkElla F Jones, John M Buatti, Hui-Kuo Shu, et al.
Oncotarget|March 8, 2011
A robust approach to enhance tumor-selective accumulation of nanoparticlesYuan Qiao, Xin Huang, Sridhar Nimmagadda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2016
Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ HybridizationMatthias Holdhoff, Gunes Guner, Fausto J Rodriguez, et al.
Frontiers in Immunology|September 30, 2024
Radiation immunodynamics in patients with glioblastoma receiving chemoradiationLindsey Sloan, Rupashree Sen, Chunnan Liu, et al.
Tomography (Ann Arbor, Mich.)|March 22, 2022
Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed GlioblastomaKaren Xu, Karthik Ramesh, Vicki Huang, et al.
Pageof 12